tiprankstipranks
Trending News
More News >
HLS Therapeutics Inc (TSE:HLS)
TSX:HLS
Canadian Market

HLS Therapeutics Inc (HLS) Income Statement

Compare
44 Followers

HLS Therapeutics Inc Income Statement

Last quarter (Q3 2025), HLS Therapeutics Inc's total revenue was $13.51M, a decrease of -4.08% from the same quarter last year. In Q3, HLS Therapeutics Inc's net income was $-3.92M. See HLS Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 56.62M$ 63.07M$ 61.47M$ 60.01M$ 56.11M
Gross Profit
$ 47.62M$ 55.45M$ 56.49M$ 56.04M$ 52.48M
Operating Expenses
$ 55.31M$ 55.45M$ 69.98M$ 62.32M$ 64.57M
Depreciation and Amortization
$ 22.72M$ 31.94M$ 34.40M$ 30.26M$ 33.19M
EBITDA
$ 17.22M$ 12.88M$ 18.00M$ 25.41M$ 23.19M
Operating Income
$ -7.69M$ -10.35M$ -13.44M$ -6.24M$ -11.26M
Other Income/Expenses
$ -7.90M$ -17.45M$ -10.22M$ -5.52M$ -4.21M
Pretax Income
$ -15.58M$ -27.80M$ -23.72M$ -11.81M$ -16.30M
Net Income
$ -19.66M$ -27.53M$ -23.60M$ -13.12M$ -15.33M
Per Share Metrics
Basic EPS
$ -0.62$ -0.85$ -0.73$ -0.41$ -0.48
Diluted EPS
$ -0.62$ -0.85$ -0.73$ -0.41$ -0.48
Weighted Average Shares Outstanding
31.84M 32.26M 32.33M 32.18M 31.71M
Weighted Average Shares Outstanding (Diluted)
31.84M 32.26M 32.43M 32.18M 31.71M
Currency in USD

HLS Therapeutics Inc Earnings and Revenue History